This article represents opinions of the author and not those of his firm and are subject to change from time to time and do not constitute a recommendation to purchase and sale any security nor to engage in any particular investment strategy. The information contained here has been obtained from ...
This is a strong contender, but we'll be keeping a close watch on firmwide developments.
Portfolio manager Wally Weitz's bets on Warren Buffett and telecoms mogul John Malone have helped his fund produce the best risk-adjusted performance among U.S. value funds in the past five years.
Ophthalmology will be more challenging for Valeant than dermatology, but the deal is highly accretive.